Nasal manifestations of systemic illnesses

Current Allergy and Asthma Reports

Volumn 4, Issue 3, 2004, Pages 208-216

  Alobid, Isam ^a   Guilemany, Jose Maria ^a   Mullol, Joaquim ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CHLOROQUINE; CLOFAZIMINE; CLOFIBRATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; DOXYCYCLINE; ETHIONAMIDE; IMMUNOGLOBULIN; ITRACONAZOLE; LEPROMIN; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN G; PREDNISONE; PROTEINASE INHIBITOR; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STEROID; TUBERCULIN; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMYLOIDOSIS; ANTIPHOSPHOLIPID SYNDROME; ASTHMA; BRONCHOPULMONARY ASPERGILLOMA; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHURG STRAUSS SYNDROME; CILIARY DYSKINESIA; CROHN DISEASE; CRYOGLOBULINEMIA; CYSTIC FIBROSIS; ENTERITIS; EPISTAXIS; GASTROESOPHAGEAL REFLUX; HEMATOLOGIC DISEASE; HUMAN; IMMUNE DEFICIENCY; LEPROSY; MULTIPLE MYELOMA; MYCOSIS; NOSE DISEASE; PARANASAL SINUS; POLYARTERITIS NODOSA; PREVALENCE; RELAPSING POLYCHONDRITIS; RESPIRATORY TRACT DISEASE; REVIEW; SARCOIDOSIS; SCLERODERMA; SJOEGREN SYNDROME; SMELLING DISORDER; SYPHILIS; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TASTE DISORDER; TUBERCULOSIS; ULCERATIVE COLITIS; WEGENER GRANULOMATOSIS; GASTROINTESTINAL DISEASE; INFECTION; PARANASAL SINUS DISEASE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CHURG-STRAUSS SYNDROME; GASTROINTESTINAL DISEASES; HEMATOLOGIC DISEASES; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; NOSE DISEASES; OLFACTION DISORDERS; PARANASAL SINUS DISEASES; POLYARTERITIS NODOSA; RESPIRATORY TRACT DISEASES; SARCOIDOSIS; SJOGREN'S SYNDROME; WEGENER GRANULOMATOSIS;

EID: 3042547299     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-004-0028-y     Document Type: Review

References (51)

1. Centers for Disease Control and Prevention: Core curriculum on tuberculosis. Available at: www.cdc.gov/nchstp/tb/pubs/ corecurr/default.htm. Accessed 1/13/03.
2. Hup AK, Haitjema T, de Kuijper G: Primary nasal tuberculosis. Rhinology 2001, 39:47-48.
3. Davis BD: Bacterial and mycotic infections: leprosy. In Microbiology, edn 3- Edited Davis BD, Dulbecco R, Eisen FIN. New York: Harper & Row; 1980.
4. Alobid I, Bernal M, Calvo C, et al.: Successful treatment of rhinocerebral mucormycosis by combination of endoscopic sinus surgery and amphotericin B. Am J Rhinol 2001, 15:327-331.
5. Pletcher SD, Cheung SW: Syphilis and otolaryngology. Otolaryngol Clin North Am 2003, 36:595-605.
6. Boot JM, Oranje AP, de Groot R, et al.: Congenital syphilis. Int J SID AIDS 1992, 3:161-167.
7. Finn DG: Lymphoma of the head and neck and acquired immunodeficiency syndrome: clinical investigation and immunohistological study. Laryngoscope 1995, 105:1-18.
8. Birchall MA, Horner PD, Stafford ND: Changing patterns of HIV infection in otolaryngology. Clin Otolaryngol 1994, 19:473-477.
9. Imamura R, Voegels R, Sperandio F, et al.: Microbiology of sinusitis in patients undergoing bone marrow transplantation. Otolaryngol Head Neck Surg 1999, 120:279-282.
10. Alexander BD: Prophylaxis of invasive mycoses in solid organ transplantation. Curr Opin Infect Dis 2002, 15:583-589.
11. James DG: Sarcoidosis and other granulomatous disorders. In Epidemiology. Edited by James DG. New York: Marcel Dekker; 1994:729-743.
12. Long CM, Smith TL, Loehrl TA, et al.: Sinonasal disease in patients with sarcoidosis. Am J Rhinol 2001, 15:211-215.
13. Cotch MF, Hoffman GS, Yerg DE, et al.: The epidemiology of Wegener's granulomatosis: estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996, 39:87-92.
14. Gubbels SP, Barkhuizen A, Hwang PH: Head and neVk manifestation of Wegener's granulomatosis. Otolaryngol Clin North Am 2003, 36:685-705.
15. Restrepo S, Rojas IC, Villamil MA, Palacios E: Wegener's granulomatosis of the nasal cavity. Ear Nose Throat 12003, 82: 100- 101.
16. Metaxaris C, Prokopakis ER Karatzanis AD, et al.: Otolaryngologic manifestations of small vessel vasculitis. Auris Nasus Larynx 2002, 29:353-356.
17. Trittel C, Moller J, Euler HH, Werner JA: Churg-Strauss syndrome: a differential diagnosis in chronic polypoid sinusitis. Laryngorhinootologie 1995, 74:577-580.
18. Uramoto KM, Michet CJ Jr, Thumboo J, et al.: Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999, 42:46-50.
19. Robson AK, Burge SM, Millard PR. Nasal mucosal involvement in ]opus erythematosus. Clin Otolaryngol 1992, 17:341-343.
20. Oristrell SJ, Bosch GJ, Valdes OM, Knobel FH: Polyarteritis nodosa and perforation of the nasal septum. Med Clin (Barc) 1985, 84:673-674.
21. Mahoney EJ, Spiegel JH: Sjogren's disease. Otolaryngol Clin North Am 2003, 36:733-745.
22. Rasmussen N, Brofetdt S, Manthorpe R: Smell and nasal findings in patients with primary Sjogren's syndrome. Scand J Rheumatol Suppl 1986, 61:142-145.
23. Willkens RF, Roth GJ, Novak A, Walike JW: Perforation of nasal septum in rheumatic diseases. Arthritis Rheum 1976, 19:119-121.
24. Callot V, Sirieix ME, Cohen P, et al.: Recurrent leg ulcers, intraalveolar hemorrhage, perforation of the nasal septum: Primary antiphospholipid syndrome? Ann Med Interne (Paris) 1995, 146:366-369.
25. Michet CJ Jr, McKenna CH, Luthra HS, O'Fallon WM: Relapsing polychondritis: survival and predictive role of early disease manifestations. Ann Intern Med 1986, 104:74-78.
26. Smith I, Smith M, Mathias D, Wallis J: Cryoglobulinaemia and septal perforation: a rare but logical cause. J Laryngol Otol 1996, 110:668-669.
27. Brignola C, Belloli C, Ardizzone S, et al.: The relationship between heritability and smoking habits in Crohn's disease. Italian Cooperative Study Group. Am J Gastroenterol 2000, 95:3171-3175.
28. Book DT, Smith TL, McNamar JP, et al.: Chronic sinonasal disease in patients with inflammatory bowel disease. Am J Rhinol 2003, 17:87-90.
29. Bachmeyer C, Laurette F, Coutarel P, et al.: Perforation of the nasal septum in hemorrhagic rectocolitis. Presse Med 1996, 25:1890.
30. Rowe FA, Walker JH, Karp LC, et al.: Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. Am J Gastroenterol 2000, 95:2000-2228.
31. Weaver FM: Association between gastroesophageal reflux and sinusitis, otitis media, and laryngeal malignancy: a systematic review of the evidence. Am J Med 2003, 115:81-89.
32. Bothwell MR, Parsons DS, Talbot A, et al.: Outcome of reflux therapy on pediatric chronic sinusitis. Otolaryngol Head Neck Surg 1999, 121:255-262.
33. Patel A, Pambuccian S, Maisel R: Nasopharyngeal amyloidosis. Am J Otolaryngol 2002, 23:308-311.
34. Gillmore JD, Lovat LB, Persey MR, et al.: Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001, 358:24-29.
35. Spitzer G: Plasma cell disorders: myeloma and related conditions. Diagnosis and management. J S C Med Assoc 2003, 99:88-93.
36. Johnston R, Altman KW, Gartenhaus RB: Chronic lymphocytic leukemia manifesting in the paranasal sinuses. Otolaryngol Head Neck Surg 2002, 127:582-584.
37. van Besien K, Keralavarma B, Devine S, Stock W: Allogeneic and autologous transplantation for chronic lymphocytic leukemia. Leukemia 2001, 15:1317-1325.
38. Schwartzbauer HR, Shete M, Tami TA: Endoscopic anatomy of the sphenopalatine and posterior nasal arteries: implications for the endoscopic management of epistaxis. Am J Rhinol 2003, 17:63-66.
39. Hurd S: The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000, 117:1-4.
40. Roberts NJ, Lloyd-Owen SJ, Rapado F, et al.: Relationship between chronic nasal and respiratory symptoms in patients with COPD. Respir Med 2003, 97!909-914.
41. Shah A, Panchal N, Agarwal AK: Concomitant allergic bronchopulmonary aspergillosis and allergic Aspergillus sinusitis: a review of an uncommon association. Clin Exp Allergy 2001, 31:1896-905.
42. Thrasher RD, Kingdom TT: Fungal infections of the head and neck: an update. Otolaryngol Clin North Am 2003, 36:577-594.
43. Smith DH, Malone DC, Lawson KA, et al.: A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997, 156:787-793.
44. Togias A: Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003, 111:1171-1183.
45. Smith JM. Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis (eczema). In Allergy: Principles and Practice, edn 2. Edited by Middleton E, Reed CE, Ellis EF., St. Louis: Mosby; 1983:771-803.
46. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group; World Health Organization: Allergic rhinitisand its impact on asthma. J Allergy Clin Immunol 2001, 108:147-334.
47. Schwartz HJ, Thompson JS, Sher TH, Ross RJ: Occult sinus abnormalities in the asthmatic patient. Arch Intern Med 1987, 147:2194-2196.
48. Picado C: Aspirin intolerance and nasal polyposis. Curr Allergy Asthma Rep 2002, 2:488-493.
49. Wang L, Freedman SD: Laboratory tests for the diagnosis of cystic fibrosis. Am J Clin Pathol 2002, 117:199-115.
50. Chin GY, Karas DE, Kashgarian M: Correlation of presentation and pathologic condition in primary ciliary dyskinesia. Arch Otolaryngol Head Neck Surg 2002, 128:1292-1294.
51. Bromley SM: Smell and taste disorders: a primary care approach. Am Fam Physician 2000, 61:427-436.